What amount sold does IlluminOss Medical Inc report in Form D filings?

The latest linked filings report $39.9M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was IlluminOss Medical Inc's most recent SEC filing?

IlluminOss Medical Inc's most recent Form D filing was on 2016-02-05.

How many investors does IlluminOss Medical Inc have?

The most recent Form D filing lists 17 investor(s).

What type of securities does IlluminOss Medical Inc offer?

IlluminOss Medical Inc's SEC Form D filings indicate equity offerings.

IlluminOss Medical Inc

CIK: 0001393857·Biotechnology·EAST PROVIDENCE, RI·Corporation

Reported Sold

$39,868,639

Total Filings

Identified Offerings

Last Filed

Feb 5, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Feb 5, 2016Form D — New notice

Reported sold: $4,997,999 · Target: $25,000,000

Rule 506(b)·17 investors

Jun 30, 2014Form D — New notice

Reported sold: $6,470,640 · Target: $22,000,002

Rule 506(b)·14 investors

Oct 5, 2012Form D — New notice

Reported sold: $19,000,000 · Target: $38,000,000

Rule 506·13 investors

Jun 28, 2012Form D — New notice

Reported sold: $400,000 · Target: $400,000

Rule 506·4 investors

Jun 28, 2012Form D — New notice

Reported sold: $1,000,000 · Target: $1,000,000

Rule 506·3 investors

Nov 29, 2011Form D — New notice

Reported sold: $4,000,000 · Target: $4,000,000

Rule 506·4 investors

Dec 1, 2010Form D — New notice

Reported sold: $4,000,000 · Target: $4,000,000

Rule 506·4 investors·Section 4(6)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 7 identified offerings

$39,868,639

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

R. Scott Rader

Related Person

Appears on 2 filings

Robert A. Rabiner

Related Person

Appears on 2 filings

Ron Hunt

Related Person

Appears on 2 filings

Daniel Omstead

Related Person

Appears on 2 filings

Fouad Azzam

Related Person

Appears on 2 filings

Rajeev Dadoo

Related Person

Appears on 2 filings

Robert Rabiner

Related Person

Appears on 2 filings

Enrico Petrillo

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 5, 2016	New	$25,000,000	$4,997,999	17
Jun 30, 2014	New	$22,000,002	$6,470,640	14
Oct 5, 2012	New	$38,000,000	$19,000,000	13
Jun 28, 2012	New	$400,000	$400,000	4
Jun 28, 2012	New	$1,000,000	$1,000,000	3
Nov 29, 2011	New	$4,000,000	$4,000,000	4
Dec 1, 2010	New	$4,000,000	$4,000,000	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Nuclein, LLC

Biotechnology

Offering target: $26,114,842

Filed Oct 27, 2026